These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT. Hanrahan CJ, Christensen CR, Crim JR. Radiographics; 2010 Jan; 30(1):127-42. PubMed ID: 20083590 [Abstract] [Full Text] [Related]
5. Hematopoietic tumors and metastases involving bone. Kim SH, Smith SE, Mulligan ME. Radiol Clin North Am; 2011 Nov; 49(6):1163-83, vi. PubMed ID: 22024293 [Abstract] [Full Text] [Related]
6. PET/CT for the staging and follow-up of patients with malignancies. Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G. Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595 [Abstract] [Full Text] [Related]
7. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Durie BG. Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405 [Abstract] [Full Text] [Related]
8. Modern imaging techniques during therapy in patients with multiple myeloma. Horger M, Weisel K, Bares R, Ernemann U, Claussen CD, Lichy M, Fenchel M. Acta Radiol; 2011 Oct 01; 52(8):881-8. PubMed ID: 21878551 [Abstract] [Full Text] [Related]
10. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence. Potter KC, Husband JE, Houghton SL, Thomas K, Brown G. Dis Colon Rectum; 2009 Feb 01; 52(2):253-9. PubMed ID: 19279420 [Abstract] [Full Text] [Related]
11. The role of whole-body imaging in the diagnosis, staging, and follow-up of multiple myeloma. Shortt CP, Carty F, Murray JG. Semin Musculoskelet Radiol; 2010 Mar 01; 14(1):37-46. PubMed ID: 20229439 [Abstract] [Full Text] [Related]
13. Advances in imaging and the management of myeloma bone disease. Terpos E, Moulopoulos LA, Dimopoulos MA. J Clin Oncol; 2011 May 10; 29(14):1907-15. PubMed ID: 21483016 [Abstract] [Full Text] [Related]
14. Fluorine-18-deoxyglucose-positron emission tomography imaging with magnetic resonance and computed tomographic correlation in the evaluation of bone and soft-tissue sarcomas: a pictorial essay. Tewfik JN, Greene GS. Curr Probl Diagn Radiol; 2008 May 10; 37(4):178-88. PubMed ID: 18502325 [Abstract] [Full Text] [Related]
15. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Tateishi U, Hosono A, Makimoto A, Nakamoto Y, Kaneta T, Fukuda H, Murakami K, Terauchi T, Suga T, Inoue T, Kim EE. Ann Nucl Med; 2009 Feb 10; 23(2):155-61. PubMed ID: 19225939 [Abstract] [Full Text] [Related]
16. [Diagnosis and follow-up with 18F-fluorodeoxiglucose positron emission tomography/computed tomography of extraosseous myeloma]. Garcia JR, Canales M, Ponce A, Buxeda M, Moragas M, Soler M. Rev Esp Med Nucl Imagen Mol; 2014 Feb 10; 33(2):115-7. PubMed ID: 23867637 [No Abstract] [Full Text] [Related]
17. Guidelines for the use of imaging in the management of myeloma. D'Sa S, Abildgaard N, Tighe J, Shaw P, Hall-Craggs M. Br J Haematol; 2007 Apr 10; 137(1):49-63. PubMed ID: 17359371 [Abstract] [Full Text] [Related]
18. Whole-body MRI for the staging and follow-up of patients with metastasis. Schmidt GP, Reiser MF, Baur-Melnyk A. Eur J Radiol; 2009 Jun 10; 70(3):393-400. PubMed ID: 19457631 [Abstract] [Full Text] [Related]
19. Update on diagnostic imaging for melanoma. Grasee EA, Wagner JD. Facial Plast Surg Clin North Am; 2003 Feb 10; 11(1):49-60. PubMed ID: 15062287 [No Abstract] [Full Text] [Related]
20. The evolution of whole-body imaging. Moran DE, Heffernan EJ. Semin Musculoskelet Radiol; 2010 Mar 10; 14(1):3-13. PubMed ID: 20229436 [Abstract] [Full Text] [Related] Page: [Next] [New Search]